We are live on
!
Find out more
MCM
Mengis Capital Management Portfolio holdings
AUM
$658M
1-Year Est. Return
39.64%
This Fund
S&P 500
This Quarter
Est. Return
+7.25%
1 Year Est. Return
+39.64%
3 Year Est. Return
+91.78%
5 Year Est. Return
+129.93%
10 Year Est. Return
+407.15%
AUM
$501M
AUM Growth
+$26.6M
(+5.6%)
Cap. Flow
-$2.62M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
40.98%
Holding
171
New
6
Increased
40
Reduced
77
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$1.14M |
| 2 |
Freeport-McMoran
FCX
|
+$672K |
| 3 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$620K |
| 4 |
Agilent Technologies
A
|
+$620K |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$549K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$3.2M |
| 2 |
US Bancorp
USB
|
+$925K |
| 3 |
Bristol-Myers Squibb
BMY
|
+$588K |
| 4 |
Merck
MRK
|
+$557K |
| 5 |
Microsoft
MSFT
|
+$484K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.86% |
| 2 | Industrials | 19.89% |
| 3 | Healthcare | 15.97% |
| 4 | Consumer Staples | 9.06% |
| 5 | Energy | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW.PRD
126
Charles Schwab 5.95% Series D Preferred Stock
SCHW.PRD
$724M
| $413K | 0.08% |
16,504
-600
| -4% | -$14.8K |
|
127
Prudential Financial
PRU
$42.7B
| $407K | 0.08% |
4,619
-2,100
| -31% | -$176K |
|
128
iShares S&P 500 Growth ETF
IVW
$75.5B
| $402K | 0.08% |
5,708
| – | – |
|
129
BorgWarner
BWA
$13B
| $379K | 0.08% |
8,804
| – | – |
|
130
Caterpillar
CAT
$382B
| $378K | 0.08% |
1,538
+26
| +2% | +$5.8K |
|
131
Viatris
VTRS
$20.5B
| $373K | 0.07% |
37,368
-1,149
| -3% | -$11K |
|
132
Cisco
CSCO
$457B
| $373K | 0.07% |
7,203
-145
| -2% | -$7.13K |
|
133
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66B
| $369K | 0.07% |
4,675
| – | – |
|
134
GE HealthCare
GEHC
$31.5B
| $345K | 0.07% |
+4,242
| New | +$339K |
|
135
Unilever
UL
$137B
| $342K | 0.07% |
5,837
+177
| +3% | +$10.5K |
|
136
iShares Core S&P Total US Stock Market ETF
ITOT
$95.7B
| $341K | 0.07% |
3,488
-785
| -18% | -$72.6K |
|
137
VanEck Morningstar International Moat ETF
MOTI
$75.3M
| $340K | 0.07% |
10,729
+400
| +4% | +$12.7K |
|
138
NVIDIA
NVDA
$5.01T
| $337K | 0.07% |
7,960
-2,560
| -24% | -$85K |
|
139
State Street SPDR S&P Biotech ETF
XBI
$9.62B
| $326K | 0.07% |
3,916
-200
| -5% | -$16.7K |
|
140
Clorox
CLX
$11.9B
| $323K | 0.06% |
2,029
-199
| -9% | -$32.1K |
|
141
Enbridge
ENB
$118B
| $301K | 0.06% |
8,104
+386
| +5% | +$14.7K |
|
142
Corteva
CTVA
$50.9B
| $296K | 0.06% |
5,162
-33
| -0.6% | -$1.93K |
|
143
Ericsson
ERIC
$33.1B
| $293K | 0.06% |
53,800
-2,300
| -4% | -$12.3K |
|
144
Williams Companies
WMB
$86.1B
| $287K | 0.06% |
8,806
-600
| -6% | -$18K |
|
145
Schwab Fundamental US Large Company Index ETF
FNDX
$27B
| $284K | 0.06% |
14,805
-750
| -5% | -$13.9K |
|
146
iShares Select Dividend ETF
DVY
$23.6B
| $283K | 0.06% |
2,500
| – | – |
|
147
Seagate
STX
$189B
| $282K | 0.06% |
4,550
+500
| +12% | +$30.5K |
|
148
Blackrock
BLK
$175B
| $280K | 0.06% |
405
| – | – |
|
149
Salesforce
CRM
$152B
| $277K | 0.06% |
1,310
-200
| -13% | -$40.8K |
|
150
Schwab International Equity ETF
SCHF
$67.1B
| $274K | 0.05% |
15,388
+122
| +0.8% | +$2.17K |
|
Similar funds
VCM
PIM
CG
CAM
BL
DAS
UCMOK
ACM
Mengis Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Mengis Capital Management held 171 positions worth $501M, up 5.6% from $475M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Mengis Capital Management's Q2 2023 filing shows 6 new, 40 increased, 77 reduced and 5 closed positions. Its largest new stake was Freeport-McMoran: 17,645 shares worth $706K. The largest sale was Vanguard Ultra-Short Bond ETF, an estimated $3.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.
- Mengis Capital Management's largest Q2 2023 buy was Freeport-McMoran: 17,645 shares worth $706K.
- Mengis Capital Management added most to PNC Financial Services in Q2 2023, an estimated $1.14M increase.
- Mengis Capital Management's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $588K.
- Mengis Capital Management fully exited Vanguard Ultra-Short Bond ETF in Q2 2023, selling an estimated $3.2M.
- Mengis Capital Management's ten largest holdings make up 41% of its $501M portfolio in Q2 2023.
- Mengis Capital Management opened 6 new positions and closed 5 in Q2 2023.
- Mengis Capital Management's portfolio value rose 5.6% quarter-over-quarter to $501M.
Based on Mengis Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.